Matches in Wikidata for { <http://www.wikidata.org/entity/Q86256309> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q86256309 description "clinical trial" @default.
- Q86256309 description "ensayu clínicu" @default.
- Q86256309 description "klinisch onderzoek" @default.
- Q86256309 description "клінічне випробування" @default.
- Q86256309 name "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors" @default.
- Q86256309 name "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors" @default.
- Q86256309 type Item @default.
- Q86256309 label "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors" @default.
- Q86256309 label "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors" @default.
- Q86256309 prefLabel "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors" @default.
- Q86256309 prefLabel "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors" @default.
- Q86256309 P1050 Q86256309-2FD23A2E-3944-4482-8317-F4E37D48DB84 @default.
- Q86256309 P1050 Q86256309-381083DC-3175-47D4-8D10-CFFA3471545A @default.
- Q86256309 P1132 Q86256309-873E09BD-8B72-43F0-AE0C-6BE819F316D0 @default.
- Q86256309 P1476 Q86256309-BDF363A6-D98D-4D72-853A-DC921BD8DFD5 @default.
- Q86256309 P2899 Q86256309-80FEC411-5121-43F9-8190-A73513AEF630 @default.
- Q86256309 P3098 Q86256309-DAE1B7D6-9CC4-472C-B0BE-08B23A3CEBDB @default.
- Q86256309 P31 Q86256309-6160BB2A-74A1-4C5D-8DA5-4A32CED15BD4 @default.
- Q86256309 P580 Q86256309-F9C51100-70B2-4EC2-8578-17C751783F57 @default.
- Q86256309 P582 Q86256309-01DA2092-B589-4124-9FBC-2F96AF22922E @default.
- Q86256309 P6099 Q86256309-51F39CCE-1F45-462F-8ACC-9FC9220A9428 @default.
- Q86256309 P8363 Q86256309-CA480249-5642-4A2E-A04D-7D014000987C @default.
- Q86256309 P1050 Q1077603 @default.
- Q86256309 P1050 Q33525 @default.
- Q86256309 P1132 "+140" @default.
- Q86256309 P1476 "A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Select Advanced Solid Tumors" @default.
- Q86256309 P2899 "+18" @default.
- Q86256309 P3098 "NCT04272034" @default.
- Q86256309 P31 Q30612 @default.
- Q86256309 P580 "2020-05-30T00:00:00Z" @default.
- Q86256309 P582 "2023-10-30T00:00:00Z" @default.
- Q86256309 P6099 Q5452194 @default.
- Q86256309 P8363 Q78089383 @default.